United States · Exchanges & live quotes · Nasdaq

PTC Therapeutics Board Approves $500 Mln Share Buyback

Published by Nasdaq · United States 1 h ago

(RTTNews) - PTC Therapeutics, Inc. (PTCT), a biopharmaceutical company, said Tuesday that its Board of Directors has authorized a share repurchase program of up to $500 million.

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

OilPrice.com

Indian Refiner BPCL Buys U.S. WTI Crude Oil Cargo

CoinMarketCap

Bitcoin ETF Tracker

CNN Markets

What to know about the possibility of federal officers showing up at polling stations

Investopedia

Here’s How Much Traders Expect Palantir Stock to Move After Earnings

Cboe Global Markets

Nasdaq and S&P 500 Index Lose Momentum, Pull Down Market

Google Finance